Rapid screener for the assessment of fear of progression in cancer survivors: The Fear of progression‐Questionnaire Rapid Screener

Youssef, Yasmin; Mehnert‐Theuerkauf, Anja; Götze, Heide; Friedrich, Michael; Esser, Peter

doi:10.1111/ecc.13400

Cited by 4 publications

(3 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Scores of 34 or above indicate dysfunctional levels of FoP [33,34]. Recently, a 5-item short-form version of the FoP-Q-12 has been developed [30], called FoP-Q-RS. Here, we prefer the notation FoP-Q-5.…”

Section: Instrumentsmentioning

confidence: 99%

“…A frequently used and validated instrument for assessing FoP in cancer patients is a short form of the FoP-Q, the FoP-Q-12 [29]. A recent study further condensed this questionnaire and extracted five items, arriving at the 5-item Fear of Progression Questionnaire-Rapid Screener (FoP-Q-RS) [30]. Another recently developed short questionnaire for measuring FoP is the Concerns About Recurrence Questionnaire CARQ-4 [31].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4)

Hinz,

Schulte,

Mehnert-Theuerkauf

et al. 2024

Healthcare

Self Cite

View full text Add to dashboard Cite

As cancer patients often suffer from fear of cancer progression (FoP), valid screening for FoP is of high relevance. The aims of this study were to test psychometric properties of two FoP questionnaires, to determine their relationship to other anxiety-related constructs, and to analyze the impact of sociodemographic and clinical factors on the FoP. Our sample consisted of n = 1733 patients with mixed cancer diagnoses. For measuring FoP, the Fear of Progression questionnaire (FoP-Q-12) and the Concerns About Cancer Recurrence Questionnaire (CARQ-4) were used. The mean scores of the FoP-Q-12 and the CARQ-4 were 30.0 ± 10.4 and 16.1 ± 10.8, respectively, indicating relatively high levels of FoP. Both questionnaires showed excellent internal consistency coefficients, α = 0.895 and α = 0.915, respectively. The correlation between the two FoP questionnaires was r = 0.72. Female patients reported more FoP than male patients (d = 0.84 and d = 0.54, respectively). There was a nonlinear age dependency of FoP, with an increase found in the age range from 18 to 50 years and a decrease in the older age range. Radiation, chemotherapy, and antibody therapy, but not surgery, lead to an increase in FoP. Both questionnaires show good psychometric properties and can be recommended for use in an oncological routine. Female patients and patients in the middle-age range deserve special attention from healthcare providers.

show abstract

Section: Instrumentsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4)

Hinz,

Schulte,

Mehnert-Theuerkauf

et al. 2024

Healthcare

Self Cite

View full text Add to dashboard Cite

show abstract

“…It is reported that 33 to 96% of cancer patients worldwide have FoP, and the proportion with severe fear reaches 87% (Lebel et al, 2016). FoP has become one of the most common psychological problems in patients with cancer, and FoP is now included in the international definition of fear of cancer recurrence (FCR; Youssef et al, 2021). FCR is fear or apprehension in cancer survivors about the possibility of cancer recurrence, progression, or metastasis at the primary site or elsewhere (Barrows et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

Fear of progression, loneliness, and hope in patients with gastrointestinal cancer: a cross-sectional relational study

Li,

Xiao,

Liao

et al. 2024

Front. Psychol.

View full text Add to dashboard Cite

IntroductionIn recent years, fear of disease progression (FoP) has become one of the most common psychological problems in cancer patients. However, there are fewer studies on the FoP in patients with gastrointestinal tumors. We aimed to assess the level of FoP in patients with gastrointestinal tumors and analyze the factors related to FoP. We also aimed to examine the relationship among loneliness, hope and FoP in patients with gastrointestinal cancer.MethodsA cross-sectional survey was conducted on three Grade A hospitals in southwestern China from November 2021 to July 2022. The demographic and clinical characteristics questionnaire, Fear of Disease Progression Scale (FoP-Q-SF), Cancer Loneliness Scale (CLS), and Herth Hope Index (HHI) were included in this study. Data analysis included descriptive statistics, independent samples t-tests, one-way analysis of variance, and multiple linear regression analysis.ResultsIn total, 245 gastrointestinal cancer patients participated in this study. The average (standard deviation) FoP score in patients was 32.94 ± 10.64. In total, 245 gastrointestinal cancer patients participated in this study. The average (standard deviation) FoP score in patients was 32.94 ± 10.64. The average score of CLS was 17.65 ± 6.71, and that for the HHI was 31.27 ± 7.73. Pearson correlation analysis showed that FoP was negatively significant correlated with hope level (r = −0.522) and FoP was positively significant correlated with loneliness (r = 0.545). Linear regression analysis showed that educational level, age, living condition, hope, and loneliness were the significant predictors of FoP and explained 53.10% of the variability in FoP (F = 16.372).ConclusionFindings highlight the need to strengthen attention to FoP in gastrointestinal cancer patients. Our study showed that gastrointestinal cancer patients who have a high school education, are age 45 to 59, live alone, high level of loneliness, and low level of hope have higher FoP. Medical staff should enhance clinical screening of FoP and consider the formulation of relevant interventions for high-risk groups to reduce loneliness among patients, raise their hope level, and reduce their FoP.

show abstract

Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors: A Systematic Review

Hampton,

Alam,

Zdenkowski

et al. 2024

Thyroid®

View full text Add to dashboard Cite

Rapid screener for the assessment of fear of progression in cancer survivors: The Fear of progression‐Questionnaire Rapid Screener

Cited by 4 publications

References 30 publications

Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4)

Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4)

Fear of progression, loneliness, and hope in patients with gastrointestinal cancer: a cross-sectional relational study

Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors: A Systematic Review

Contact Info

Product

Resources

About